The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
March 12th 2025
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a combination antiretroviral therapy (ART) in its long-acting injectable form.
V-BID X: A Template for Aligning Cost Sharing With Value of Services
July 30th 2019The University of Michigan Center for Value-Based Insurance Design (V-BID), in collaboration with a group of healthcare stakeholders, has announced the details of V-BID X, a template for reducing cost sharing for certain high-value services and raising cost sharing for certain low-value services while not increasing premiums or deductibles.
Read More
Dr Mark Fendrick on the Importance of Low, No Cost Sharing in HIV Care, Other Public Health Issues
July 24th 2019A. Mark Fendrick, MD, professor of Medicine in the School of Medicine, professor of Health Management and Policy in the School of Public Health, and director of the VBID Center at the University of Michigan, discusses how low or no cost sharing for high-value services is particularly important for public health issues or epidemics, such as HIV.
Watch
The Senate on Tuesday approved funding for the September 11th Victim Compensation Fund through 2090; the FDA is warning a leading marijuana company against illegally selling unapproved products containing cannabidiol (CBD); an implanted HIV drug may someday be able to prevent HIV for up to a year.
Read More
While PrEP Use Has Skyrocketed Among Urban MSM, Geographic Access Lags Elsewhere
July 22nd 2019As the CDC released data showing an approximate 500% increase in the use of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in urban areas between 2014 and 2017, a study published in the American Journal of Public Health revealed that a significant amount of MSM elsewhere live in PrEP-access deserts.
Read More
Global Phase 3 Study Will Determine Efficacy of HIV Prevention Vaccine
July 15th 2019The HPX3002/HVTN, or Mosaico, trial will determine if the vaccine regimen can induce immune responses against various global HIV strains among 3800 men who have sex with men and transgender people aged between 18 and 60 years.
Read More
Researchers Successfully Eliminate HIV in Mice With the Help of CRISPR
July 8th 2019Combining CRISPR with long-acting slow-effective release antiretroviral therapy—a recently developed therapeutic strategy—the researchers were able to effectively eliminate replication-competent HIV DNA from the genomes of approximately 30% of infected humanized mice.
Read More
Dr Stella Safo: HIV Care Has Always Been Willing to Think Outside the Box
July 8th 2019While the health system transitions to value-based care, it can learn a lot of lessons from HIV care delivery, said Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch
Dr Mark Fendrick on USPSTF's Grade A Recommendation for HIV Screening, PrEP for HIV Prevention
July 2nd 2019A. Mark Fendrick, MD, professor of medicine in the School of Medicine, professor of health management and policy in the School of Public Health, and director of the VBID Center at the University of Michigan, discusses how the United States Preventive Services Task Force's grade A recommendation for HIV screening and pre-exposure prophylaxis for HIV prevention for high-risk populations falls in line with value-based insurance design principles.
Watch
Dr Stella Safo on Challenges With Managing HIV Costs in Shift to Value-Based Care
June 27th 2019It's important to have different metrics when it comes to cost containment because some patients are just sicker than others, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch
Researchers Identify Immune Cells at Frontline of HIV Infection Found in Genital Tissue
June 25th 2019According to the researchers, these cells are more susceptible to HIV infection, support the highest levels of infection, and are the more likely to transfer HIV to CD4 T cells following infection.
Read More
Harris Introduces Bill That Would Require All Insurance Plans to Cover PrEP and Related Services
June 21st 2019The PrEP Access and Coverage Act would require all private and public insurance plans to cover pre-exposure prophylaxis (PrEP) for HIV prevention and related services with no out-of-pocket costs and would promote access to the prevention pill for the uninsured.
Read More
Dr Stella Safo Discusses the Impact of Value-Based Care on People Living With HIV
June 14th 2019HIV care delivery has always had an ethos in it of really being based on a team-based approach, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch
This Week in Managed Care: June 14, 2019
June 14th 2019This week, the top managed care news included the Community Oncology Alliance submitting an alternative to the Oncology Care Model; more study results demonstrating diabetes drugs can prevent renal failure; US task force recommending pre-exposure prophylaxis for HIV prevention.
Watch
USPSTF Issues Recommendation Statements on PrEP, Screening for HIV
June 11th 2019The United States Preventive Services Task Force (USPSTF) has issued 2 recommendation statements including 3 grade A recommendations for the use of pre-exposure prophylaxis (PrEP) for HIV prevention and HIV screening in adults, adolescents, and pregnant women.
Read More
Ending the HIV Epidemic: Why the US Is in the Position to Do So
June 5th 2019During the Center for Strategic & International Studies’ event “HIV/AIDS in the Unites States: The Road to 2030,” Anthony S. Fauci, MD, director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, and Robert Redfield, MD, director, CDC, joined to explain why the country is ready and able to end the epidemic from both a policy and clinical perspective.
Read More
Dr Stella Safo Emphasizes the Importance of PrEP for Ending the HIV Epidemic
June 1st 2019Pre-exposure prophylaxis (PrEP) is one of the best interventions we have for preventing and stopping HIV transmission, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch
Dr Stella Safo Outlines Challenges Associated With Aging HIV Populations
May 24th 2019From the health system perspective, there needs to be improvement in treating HIV as a comprehensive disease that now goes into aging, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Watch